US3965256A
(en)
|
1972-05-16 |
1976-06-22 |
Synergistics |
Slow release pharmaceutical compositions
|
IE49324B1
(en)
|
1979-12-19 |
1985-09-18 |
Euro Celtique Sa |
Controlled release compositions
|
US4457933A
(en)
|
1980-01-24 |
1984-07-03 |
Bristol-Myers Company |
Prevention of analgesic abuse
|
US4987136A
(en)
|
1982-03-16 |
1991-01-22 |
The Rockefeller University |
Method for controlling gastrointestinal dysmotility
|
HU190619B
(en)
|
1983-11-11 |
1986-09-29 |
Bezzegh,Denes,Hu |
Process for producing tablets with controlled dissolution of active ingredients
|
DE3581428D1
(de)
|
1984-06-13 |
1991-02-28 |
Roehm Gmbh |
Verfahren zum ueberziehen von arzneiformen.
|
US4785000A
(en)
|
1986-06-18 |
1988-11-15 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
US4769372A
(en)
|
1986-06-18 |
1988-09-06 |
The Rockefeller University |
Method of treating patients suffering from chronic pain or chronic cough
|
US5004613A
(en)
|
1987-07-27 |
1991-04-02 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
FR2653337B1
(fr)
|
1989-10-23 |
1992-02-07 |
Dow Corning Sa |
Element a liberation prolongee et procede pour le fabriquer.
|
JPH03232814A
(ja)
|
1990-02-08 |
1991-10-16 |
Shin Etsu Chem Co Ltd |
徐放性錠剤の製造方法
|
DE4325465B4
(de)
|
1993-07-29 |
2004-03-04 |
Zenz, Michael, Prof. Dr.med. |
Orales pharmazeutisches Präparat für die Schmerztherapie
|
US5662933A
(en)
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
DE4443105C2
(de)
|
1994-12-03 |
1997-03-13 |
Hoechst Ag |
Verfahren zur Herstellung Molsidomin-haltiger Tabletten
|
US6488961B1
(en)
|
1996-09-20 |
2002-12-03 |
Ethypharm, Inc. |
Effervescent granules and methods for their preparation
|
DE19651551C2
(de)
|
1996-12-11 |
2000-02-03 |
Klinge Co Chem Pharm Fab |
Opioidantagonisthaltige galenische Formulierung
|
PL190293B1
(pl)
|
1997-02-14 |
2005-11-30 |
Goedecke Ag |
Sposób stabilizowania naloksonu i jego soli, stały półstały lub ciekły lek, zawierający nalokson i jego sole oraz zastosowanie środków stabilizujących do zapobiegania dimeryzacji naloksonu
|
DE69834195T2
(de)
|
1997-07-02 |
2007-03-29 |
Euro-Celtique S.A. |
Stabilisierte tramadol formulierungen mit verzögerter freisetzung
|
ATE210983T1
(de)
|
1997-11-03 |
2002-01-15 |
Stada Arzneimittel Ag |
Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
SI1685839T1
(sl)
|
1997-12-22 |
2013-08-30 |
Euro-Celtique S.A. |
Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
|
TWI223598B
(en)
|
1998-06-22 |
2004-11-11 |
Pfizer Ireland Pharmaceuticals |
An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
|
US6071952A
(en)
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
ATE275402T1
(de)
|
1999-11-01 |
2004-09-15 |
John Rhodes |
Arzneimittel zur behandlung von darmverstopfung und reizkolon
|
DE10003757A1
(de)
|
2000-01-28 |
2001-08-02 |
Knoll Ag |
Ibuprofen-Wirkstoffzubereitung
|
US6716449B2
(en)
|
2000-02-08 |
2004-04-06 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
EP2092936B1
(en)
|
2000-02-08 |
2013-03-20 |
Euro-Celtique S.A. |
Tamper-resistant oral opioid agonist formulations
|
US20040115133A1
(en)
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
GB0102342D0
(en)
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
WO2002092059A1
(en)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
WO2002092060A1
(en)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant controlled-release opioid dosage form
|
CA2449519A1
(en)
|
2001-06-08 |
2002-12-19 |
Endo Pharmaceuticals, Inc. |
Controlled release dosage forms using acrylic polymer, and process for making the same
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
WO2003013479A1
(en)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Compositions and methods to prevent abuse of opioids
|
IL160222A0
(en)
|
2001-08-06 |
2004-07-25 |
Euro Celtique Sa |
Opioid agonist formulations with releasable and sequestered antagonist
|
ES2345327T3
(es)
|
2001-08-23 |
2010-09-21 |
N.V. Organon |
Proceso para la preparacion de un derivado de 14-hidroxinormorfinona.
|
DE10144726B4
(de)
|
2001-09-11 |
2006-10-05 |
T-Mobile Deutschland Gmbh |
Verfahren zur Bereitstellung und Zuteilung von Rufnummern in einem Telekommunikationsnetz
|
DE10146275A1
(de)
|
2001-09-18 |
2003-04-24 |
Gruenenthal Gmbh |
Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
|
MXPA04008772A
(es)
|
2002-03-14 |
2004-12-06 |
Euro Celtique Sa |
Composiciones de clorhidrato de naltrexona.
|
ES2546010T3
(es)
|
2002-04-05 |
2015-09-17 |
Euro-Celtique S.A. |
Preparación farmacéutica que contiene oxicodona y naloxona
|
DE10215131A1
(de)
|
2002-04-05 |
2003-10-16 |
Euro Celtique Sa |
Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
|
WO2004004683A1
(en)
|
2002-07-04 |
2004-01-15 |
Janssen Pharmaceutica N.V. |
Solid dispersions comprising two different polymer matrixes
|
WO2004091623A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals. Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
CA2521369A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals, Inc. |
The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome
|
WO2004091665A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals, Inc. |
Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist
|
MXPA05011703A
(es)
|
2003-04-30 |
2006-01-23 |
Purdue Pharma Lp |
Forma de dosis transdermica resistente a los retardadores que comprende un componente de agente activo y un componente de agente adverso en el sitio distal de la capa del agente activo.
|
US9114199B2
(en)
|
2003-07-31 |
2015-08-25 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices containing acrylic copolymer for controlled delivery of therapeutic agent
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
CA2541371C
(en)
|
2003-10-03 |
2014-12-16 |
Atul M. Mehta |
Extended release formulations of opioids and method of use thereof
|
US20050079221A1
(en)
|
2003-10-10 |
2005-04-14 |
Groenewoud Pieter Jurjen |
Ibuprofen narcotic composition and method for making same
|
US20050232987A1
(en)
|
2004-03-12 |
2005-10-20 |
Viswanathan Srinivasan |
Dosage form containing a morphine derivative and another drug
|
US20050165038A1
(en)
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
PL1864987T3
(pl)
|
2004-02-06 |
2010-05-31 |
Euro Celtique Sa |
Sposób wytwarzania 3-O-zabezpieczonych morfinonów i karboksylanów 3-O-zabezpieczonych dienoli morfinonu
|
TWI350762B
(en)
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
US9016221B2
(en)
|
2004-02-17 |
2015-04-28 |
University Of Florida Research Foundation, Inc. |
Surface topographies for non-toxic bioadhesion control
|
TWI483944B
(zh)
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
US7700626B2
(en)
|
2004-06-04 |
2010-04-20 |
Adolor Corporation |
Compositions containing opioid antagonists
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
JP2006076971A
(ja)
|
2004-09-13 |
2006-03-23 |
Basf Ag |
口腔内崩壊錠
|
EP1814528A2
(en)
|
2004-10-08 |
2007-08-08 |
Rubicon Research Private Limited |
Process for making a highly compressible controlled delivery compositions of metformin
|
GB0423103D0
(en)
|
2004-10-19 |
2004-11-17 |
Boots Healthcare Int Ltd |
Therapeutic agents
|
CA2595329A1
(en)
|
2005-01-20 |
2006-07-27 |
Progenics Pharmaceuticals, Inc. |
Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
|
BRPI0606339A2
(pt)
|
2005-01-28 |
2009-06-16 |
Euro Celtique Sa |
formas farmacêuticas resistentes a álcool
|
EP1695700A1
(en)
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
WO2006092064A1
(en)
|
2005-03-04 |
2006-09-08 |
Intelgenx Corporation |
Delayed release pharmaceutical oral dosage form and method of making same
|
JP4741865B2
(ja)
|
2005-03-24 |
2011-08-10 |
共和薬品工業株式会社 |
ペルゴリド錠剤の製造方法
|
US20070026025A1
(en)
|
2005-04-12 |
2007-02-01 |
Aquegel Cosmetics, Llc |
Topical ointment and method for making and using same
|
MX2007014713A
(es)
|
2005-05-25 |
2008-02-14 |
Janssen Pharmaceutica Nv |
Formulacion pediatrica de topiramato.
|
TWI366460B
(en)
|
2005-06-16 |
2012-06-21 |
Euro Celtique Sa |
Cannabinoid active pharmaceutical ingredient for improved dosage forms
|
US20070059360A1
(en)
|
2005-07-29 |
2007-03-15 |
Ashish Jaiswal |
Water-dispersible anti-retroviral pharmaceutical compositions
|
US20070048364A1
(en)
|
2005-08-04 |
2007-03-01 |
Yingxu Peng |
Free flowing granules containing carbomer
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
PL1962808T3
(pl)
|
2005-12-14 |
2011-03-31 |
Hoffmann La Roche |
Preparat proleku przeciw HCV
|
US20070141147A1
(en)
|
2005-12-21 |
2007-06-21 |
Auriga Laboratories, Inc. |
Sequential release pharmaceutical formulations
|
EP1813276A1
(en)
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US7799790B2
(en)
|
2006-07-20 |
2010-09-21 |
Helm Ag |
Amorphous aripiprazole and process for the preparation thereof
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
DE102006051020A1
(de)
|
2006-10-26 |
2008-04-30 |
Evonik Röhm Gmbh |
Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
|
GB2447898B
(en)
|
2007-03-24 |
2011-08-17 |
Reckitt Benckiser Healthcare |
A tablet having improved stability with at least two actives
|
WO2010003963A1
(en)
|
2008-07-07 |
2010-01-14 |
Euro-Celtique S.A. |
Use of opioid antagonists for treating urinary retention
|
JP5827123B2
(ja)
|
2008-09-16 |
2015-12-02 |
ウェルズ ファーゴ バンク ナショナル アソシエイション |
乱用の可能性が低いpeg化オピオイド
|
DK2379066T3
(da)
|
2008-09-16 |
2014-06-30 |
Imunek Farma Ilaç Sanayi Ve Ticaret A S |
Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme
|
US20110165248A1
(en)
|
2008-09-18 |
2011-07-07 |
Meridith Lee Machonis |
Pharmaceutical dosage forms comprising poly(e-caprolactone)
|
CA2738197C
(en)
|
2008-09-24 |
2016-01-05 |
Evonik Roehm Gmbh |
Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
|
WO2010034342A1
(en)
|
2008-09-24 |
2010-04-01 |
Evonik Röhm Gmbh |
Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
|
PT2352494T
(pt)
|
2008-10-30 |
2019-11-15 |
Gruenenthal Gmbh |
Novas e potentes formas de dosagem de tapentadol
|
US20100143486A1
(en)
|
2008-12-10 |
2010-06-10 |
Nipun Davar |
Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
|
WO2010078486A2
(en)
|
2008-12-31 |
2010-07-08 |
Upsher-Smith Laboratories, Inc. |
Opioid-containing oral pharmaceutical compositions and methods
|
KR20110104097A
(ko)
|
2009-01-09 |
2011-09-21 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
불소 함유 화합물 및 이의 사용방법
|
WO2010085641A1
(en)
|
2009-01-22 |
2010-07-29 |
Noramco, Inc. |
Process for preparing particles of opioids and compositions produced thereby
|
NZ594208A
(en)
|
2009-02-06 |
2012-10-26 |
Egalet Ltd |
Pharmaceutical compositions resistant to abuse
|
PL2398808T3
(pl)
|
2009-02-17 |
2014-04-30 |
Mallinckrodt Llc |
Sposób redukcyjnego alkilowania normorfinanów
|
WO2010096790A1
(en)
|
2009-02-23 |
2010-08-26 |
Mallinckrodt Inc. |
(+)-morphinananium n-oxides and processes for their production
|
JP5784507B2
(ja)
|
2009-02-23 |
2015-09-24 |
マリンクロッド エルエルシー |
(+)−モルフィナニウム第四級塩およびその生成方法
|
US20100227876A1
(en)
|
2009-03-06 |
2010-09-09 |
Rechfensen Llp |
Methods of Reducing Side Effects of Analgesics
|
KR20110133602A
(ko)
|
2009-03-10 |
2011-12-13 |
유로-셀티큐 에스.에이. |
옥시코돈 및 날록손을 포함하는 즉시 방출 제약 조성물
|
SI2408436T1
(sl)
|
2009-03-18 |
2017-06-30 |
Evonik Roehm Gmbh |
Farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola, ki uporablja oplaščenje, ki vsebuje nevtralne vinil polimere in ekscipiente
|
KR20120003436A
(ko)
|
2009-03-18 |
2012-01-10 |
에보니크 룀 게엠베하 |
중합체 혼합물 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물
|
WO2010112942A1
(en)
|
2009-04-02 |
2010-10-07 |
Shire Llc |
Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof
|
WO2010120232A1
(en)
|
2009-04-14 |
2010-10-21 |
Yki, Ytkemiska Institutet Ab |
A prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery
|
WO2010123999A2
(en)
|
2009-04-21 |
2010-10-28 |
Auspex Pharmaceuticals, Inc. |
1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
|
EP2421507B1
(en)
|
2009-04-24 |
2019-01-23 |
Fertin Pharma A/S |
Chewing gum and particulate material for controlled release of active ingredients
|
WO2010141505A1
(en)
|
2009-06-01 |
2010-12-09 |
Protect Pharmaceutical Corporation |
Abuse-resistant delivery systems
|
GB0909680D0
(en)
|
2009-06-05 |
2009-07-22 |
Euro Celtique Sa |
Dosage form
|
ES2598496T3
(es)
|
2009-06-11 |
2017-01-27 |
Mallinckrodt Llc |
Preparación de 6-alfa-amino morfinanos N-sustituidos por transferencia de hidrógeno catalítico
|
FR2946533A1
(fr)
|
2009-06-12 |
2010-12-17 |
Ethypharm Sa |
Reduction des fluctuations plasmatiques d'opioides.
|
US8829020B2
(en)
|
2009-07-16 |
2014-09-09 |
Mallinckrodt Llc |
Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
|
CA2765971C
(en)
|
2009-07-22 |
2017-08-22 |
Gruenenthal Gmbh |
Hot-melt extruded controlled release dosage form
|
AU2010275755B2
(en)
|
2009-07-22 |
2014-04-24 |
Grünenthal GmbH |
Oxidation-stabilized tamper-resistant dosage form
|
GB0914338D0
(en)
|
2009-08-17 |
2009-09-30 |
Johnson Matthey Plc |
Improved process
|
RU2600736C2
(ru)
|
2009-09-08 |
2016-10-27 |
Сигничер Терапьютикс, Инк. |
Композиции, содержащие расщепляемые ферментами опиоидные пролекарства с модифицированным кетоном и их дополнительные ингибиторы
|
US8901113B2
(en)
|
2009-09-30 |
2014-12-02 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
US20110077222A1
(en)
|
2009-09-30 |
2011-03-31 |
Mallinckrodt Inc. |
Sustained-Release Opiate and Opiate Derivative Compositions
|
US20110150989A1
(en)
|
2009-12-22 |
2011-06-23 |
Mallinkckrodt Inc. |
Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
|
US8597681B2
(en)
|
2009-12-22 |
2013-12-03 |
Mallinckrodt Llc |
Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
|
CN102724705B
(zh)
|
2009-12-25 |
2015-04-29 |
华为技术有限公司 |
一种报告缓存数据量的方法及装置
|
KR20130030261A
(ko)
|
2010-05-10 |
2013-03-26 |
유로-셀티큐 에스.에이. |
활성제-무함유 과립 및 그를 포함하는 정제의 제조
|
JP5840201B2
(ja)
|
2010-05-10 |
2016-01-06 |
ユーロ−セルティーク エス.エイ. |
活性剤を負荷した顆粒と追加の活性剤の組合せ
|
GB2492037A
(en)
*
|
2010-05-10 |
2012-12-19 |
Euro Celtique Sa |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
MY165149A
(en)
|
2010-08-13 |
2018-02-28 |
Euro Celtique Sa |
Use of binders for manufacturing storage stable formulations
|
GB201020895D0
(en)
|
2010-12-09 |
2011-01-26 |
Euro Celtique Sa |
Dosage form
|
CA2822528C
(en)
|
2010-12-28 |
2017-07-18 |
Euro-Celtique S.A. |
A combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
|
KR20140075704A
(ko)
|
2011-10-06 |
2014-06-19 |
그뤼넨탈 게엠베하 |
오피오이드 작용제 및 오피오이드 길항제를 포함하는 변형억제 경구용 약제학적 용량형
|
CA2795324C
(en)
|
2012-11-09 |
2015-07-14 |
Purdue Pharma |
Pharmaceutical compositions comprising hydromorphone and naloxone
|
CN112716955A
(zh)
|
2013-11-13 |
2021-04-30 |
欧洲凯尔特公司 |
用于治疗疼痛和阿片样物质肠功能障碍综合征的氢吗啡酮和纳洛酮
|